#USA #White Plains #Medtronic #Retia Medical #Argos Cardiac Monitor

Retia Medical Boosts Expansion in Western Europe

Retia Medical, recognized for its innovative cardiovascular intelligence software, has recently broadened its commercial partnership with Medtronic to include the distribution of its Argos® Cardiac Output Monitor in Western Europe. This strategic move signifies Retia Medical's commitment to improving patient outcomes in the critical care landscape across the region.

The Significance of the New Partnership

The newly forged relationship with Medtronic allows Retia Medical to showcase its advanced hemodynamic monitoring technology to clinicians responsible for high-risk surgical and critically ill patients within Western European hospitals. Hemodynamic instability, a condition often observed in critical patients, is a major cause of complications and can escalate quickly without timely intervention. Continuous hemodynamic monitoring provided by Argos is vital for early detection of issues, enabling healthcare providers to deliver proactive treatment. Clinical studies indicate that effective hemodynamic interventions can lead to a significant reduction in the number of days patients spend in the Intensive Care Unit (ICU).

Marc Zemel, Co-Founder and CEO of Retia Medical, expressed the urgency of penetrating the Western European market, calling it one of the most crucial critical care markets globally. He noted that making calibration-free hemodynamic monitoring readily available to more healthcare professionals is a priority. This expansion not only builds upon Retia Medical's strong clinical foundation achieved in the United States but also extends the same quality of cardiovascular data into Europe.

On the other hand, Marc De Martini, Vice President of Western Europe for Acute Care Monitoring at Medtronic, emphasized the importance of accurate hemodynamic monitoring in personalizing patient care for high-risk individuals. The integration of devices like the Argos Cardiac Output Monitor enriches their portfolio, enabling clinicians to make well-informed decisions and improve patient outcomes significantly.

About the Argos® Cardiac Output Monitor

The Argos Cardiac Output Monitor distinguishes itself with its Multi-Beat Analysis (MBA®) technology, a sophisticated algorithm developed through collaboration between the Massachusetts Institute of Technology and Michigan State University. Unlike traditional monitors that review a single heartbeat, the MBA method analyzes multiple consecutive heartbeats, allowing for a more precise understanding of vascular resistance. This capability proves valuable, especially during conditions of low cardiac output and arrhythmias.

The Argos monitor connects easily to a patient's existing arterial line using a reusable cable, negating the need for calibration and ensuring operational readiness in under a minute, significantly cutting down setup time.

In addition to its operational efficiency, the monitor features a user-friendly touch interface that can be mastered in just five minutes, thus facilitating smoother integration into the hospital workflow.

About Retia Medical

Retia Medical stands as a pioneering force in transforming standard physiological monitoring into actionable cardiovascular insights. The company has developed the patented Multi-Beat Analysis® algorithm, which underpins both the Argos® Cardiac Output Monitor and their Argos Infinity™ software platform. This latter device also provides ongoing cardiac output and fluid responsiveness monitoring through existing medical infrastructure in both bedside and tele-ICU settings.

Retia Medical's devices have gained FDA clearance and are being utilized in numerous leading hospitals across the United States. The company continues to further its reach and application of hemodynamic intelligence in various care environments globally.

For further information on Retia Medical and its innovations, you can explore their website and find them on LinkedIn. Likewise, more insights regarding Medtronic can be retrieved at their official website.

References:
1. Hamilton MA, et al. Anesth Analg. 2011;112(6):1392–1402.
2. Giglio M, et al. Crit Care. 2019;23(1):232.